Skip to main content
. 2023 Nov 6;13(11):e064240. doi: 10.1136/bmjopen-2022-064240

Figure 3.

Figure 3

National (A) and subnational (B) seroprevalence estimates of SARS-CoV-2 antibodies over time in the WHO European Region (1 January 2020–31 December 2021).